Tm Bioscience Supplies Labcorp With Tag-It Cystic Fibrosis Reagents
News Oct 14, 2005
Tm Bioscience Corporation has announced that it is now supplying Laboratory Corporation of America Holdings with Tag-It CF70 reagents for use in their 70 mutation cystic fibrosis assay.
“We are delighted that LabCorp, one of the foremost providers of diagnostic testing in the U.S., has adopted additional products from our standardized Tag-It menu,” said Greg Hines, President and CEO of Tm Bioscience.
“Our CF70 reagents are the latest in a suite of products Tm has developed enabling high throughput laboratories to better serve the burgeoning CF market with more competitive and comprehensive offerings.”
“These reagents will allow LabCorp to serve additional segments of the ethnically diverse U.S. population.”
As previously announced, LabCorp has signed a master purchase agreement with Tm for the Company’s suite of Tag-It products.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE